Determination of the three-dimensional structure of toxins by protein crystallography

Toxicon

Volumn 38, Issue 10, 2000, Pages 1307-1353

  Souza, Dulce H F ^a   Selistre De Araujo, Heloisa S ^a   Garratt, Richard C ^b  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN; METALLOPROTEINASE; NEUROTOXIN; PHOSPHOLIPASE A2; SERINE PROTEINASE; TOXIN;

CHEMICAL STRUCTURE; CRYSTALLIZATION; CRYSTALLOGRAPHY; MACROMOLECULE; MODEL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; TECHNIQUE; X RAY DIFFRACTION;

EID: 0034102778     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(99)00200-7     Document Type: Review

References (139)

1. Arndt V.W., Wonacott A.J. Rotation Method in Crystallography Data Collection from Macromolecular Crystals. 1977;North Holland Publishing Company, Amsterdam.
2. Arni R.K., Ward R.J., Gutierrez J.M., Tulinsky A. Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom. Acta Crystallogr. D. 51:1995;311-317.
3. 2: a structural review. Toxicon. 34:1996;827-841.
4. 2-homologue from Bothrops moojeni venom. Prot. Pep. Lett. 4:1997;329-334.
5. 2-homologue from Bothrops pirajai venom. Toxicon. 36:(10):1997;1395-1406.
6. Baldwin E.T., Crumly K.V., Carter C.W. Practical, rapid screening of protein crystallization conditions by dynamic light scattering. Biophys. J. 49:1986;47.
7. Bernstein F.C., Koetzle T.F., Williams G.J., Meyer E.E. Jr, Brice M.D., Rodgers J.R., Kennard O., Shimanouch T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
8. Bhaskaran R., Huang C.C., Tsai Y.C., Jayaraman G., Chang D.K., Yu C. Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins. J. Biol. Chem. 269:(38):1994;23500-23508.
9. Bilwes A., Rees B., Moras D., Ménez R., Ménez A. X-ray structure at 1.55 Å of toxin γ, a cardiotoxin from Naja nigricollis venom. J. Mol. Biol. 239:1994;122-136.
10. Bjarnason J.B., Fox J.W. Hemorragic metalloproteinases from snake venoms. Pharmacol. Ther. 62:1994;325-372.
11. Blundell T.L., Johnson L.N. Protein Crystallography. 1976;Academic Press, New York.
12. Botos I., Scapozza L., Shannon J.D., Fox J., Meyer E. Structure-based analysis of inhibitor binding to Ht-d. Acta Crystallogr. D. 51:1995;597-604.
13. Branden C.I., Jones T.A. Between objectivity and subjectivity. Nature. 343:1990;687-689.
14. Branden C., Tooze J. Introduction to Protein Structure. 1991;Garland Publishing, New York and London.
15. Brünger A.T., Clore G.M., Gronenborn A.M., Karplus M. Solution conformations of human growth hormone releasing factor: comparison of the restrained molecular dynamics and distance geometry methods for a system without long-range distance data. Protein Eng. 1:(5):1987;399-406.
16. Brünger A.T. Isaacs N.W., Taylor M.R. Crystallographic Computing. 1988;Oxford University Press.
17. Brünger A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystals structures. Nature. 355:1992;472-474.
18. Brünger A.T., Adams P.D., Rice L.M. New applications of simulated annealing in X-ray crystallography and solution NMR. Structure. 5:1997;325-336.
19. Brünger A.T., Adams P.D., Rice L.M. New applications of simulated annealing in X-ray crystallography and solution NMR. Structure. 5:1997;325-336.
20. Carter C.W. Jr., Carter C.W. Protein crystallization using incomplete factorial experiments. J. Biol. Chem. 12:1979;219-223.
21. Cirilli M., Gallina C., Gavuzzo E., Giordano C., Gomis-Rüth F.X., Gorini B., Kress L.F., Mazza F., Paglialunga Paradisi M., Pochetti G., Politi V. 2 Å X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode. FEBS Lett. 418:1997;319-322.
22. Corfield P.W.R., Lee T.J., Low B.W. The crystal structure of erabutoxin at 2.0 Å resolution. J. Biol. Chem. 264:1989;9239-9242.
23. Creighton T.E. Proteins-Structures Molecular and Properties. 2 :1993;W.H. Freeman and Company, New York.
24. Dauter Z., Lamzin V.S., Wilson K.S. Proteins at atomic resolution. Curr. Opin. Struct. Biol. 5:1995;784-790.
25. Day J., McPherson A. Macromolecular crystal growth experiments on international microgravity laboratory. Protein Sci. 1:1992;1254-1268.
26. DeLucas L.J., Bugg C.E. New directions in protein crystal growth. Trends Biotechnol. 5:1987;188-193.
27. 2. Nature. 289:1981;604-606.
28. 2. J. Mol. Biol. 168:1983;163-179.
29. Drenth J. Principles of Protein X-ray Crystallography. 1994;Springer-Verlag New York, New York, USA.
30. Ducruix A., Giegé R. Crystallization of Nucleic Acids and Proteins: The Practical Approach Series. 1992;Oxford University Press, New York, USA.
31. Eisenberg D., Hill C.P. Protein crystallography: live surprises ahead. Trends Biochem. Sci. 14:1989;260-264.
32. Engh R.A., Huber R. Accurate bond and angle parameters for X-ray structure refinement. Acta Crystallogr. A. 47:1991;392-400.
33. Ferre-D'Amare A.R., Burley S.K. Use of dynamic light scattering to assess crystallizability of macromolecules and macromolecular assemblies. Structure. 2:(5):1994;357-359.
34. 2 at 2.4 Å resolution. Acta Crystallogr. B. 47:1991;558-559.
35. Fujimura Y., Ikeda Y., Miura S., Yoshida E., Shima H., Nishida S., Suzuki M., Titani K., Taniuchi Y., Kawasaki T. Isolation and characterization of jararaca GPIb-BP. A snake venom antagonist specific to platelet glycoprotein Ib. Thromb. Haemost. 74:1995;743-750.
36. Fujinaga M., Gros P., van Gunsteren W.F. Testing the method of crystallographic refinement using molecular dynamics. J. Appl. Crystallogr. 22:1989;1-8.
37. Garcia-Ruiz J.M., Moreno A., Otálora F., Rondón D. Teaching protein crystallization by the gel acupuncture method. J. Chem. Educ. 75:(4):1998;442-446.
38. Garman E.F., Mitchell E.P. Glycerol concentrations required for cryoprotection of 50 typical protein crystallization solutions. J. Appl. Crystallogr. 29:1996;584-587.
39. 2. Annu. Ver. Biochem. 64:1995;653-688.
40. Gernert K.M., Smith R., Carter A.D. The simple apparatus goes controlling nucleation and size in protein crystal growth. Anal. Biochem. 168:1988;141-147.
41. Giacovazzo C., Monaco H.L., Viterbo D., Scordari F., Gilli G., Zanotti G., Catti M. Fundamentals of Crystallography. 1992;Oxford University Press, New York, USA.
42. Giegé R. Crystallography in Molecular Biology. NATO ASI Series. 126:1987;15-26 Plenum Press, New York and London.
43. Glusker J.P., Lewis M., Rossi M. Crystal structure analysis for Chemists and Biologists. 1994;VCH Publishers, New York, USA.
44. Gomis-Rüth F.-X., Kress L.F., Bode W. First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinase/collagenases. EMBO J. 12:1993;4151-4157.
45. Gomis-Rüth F.X., Meyer E.F., Kress L.F., Politi V. Structures of adamalysin II with peptidic inhibitors. Implications for the design of tumor necrosis factor α convertase inhibitors. Protein Sci. 7:1998;283-292.
46. Greer J. Three-dimensional pattern recognition: an approach to automated interpretation of electron density maps of proteins. J. Mol. Biol. 82:(3):1974;279-301.
47. Guan A.L., Retzios A.D., Henderson G.N., Markland F.S. Jr. Purification and characterization of a fibrinolytic enzyme from venom of the southern copperhead snake Agkistrodon contortrix contortrix. Arch. Biochem. Biophys. 289:1991;197-207.
48. Guenneugues M., Drevet P., Pinkasfeld S., Gilquin B., Ménez A., Zinn-Justin S. Picosecond to hour time scale dynamics of a 'three finger' toxin: correlation with its toxic and antigenic properties. Biochemistry. 36:1997;16097-16108.
49. Gulewicz K., Adamaik D., Sprinzl M. The new approach to the crystallization of proteins. FEBS Lett. 189:1985;179-182.
50. 2 myotoxins from Bothrops snake venoms. Toxicon. 33:1995;1405-1424.
51. Harel M., Kleywegt G.J., Ravelli R.B.G., Silman I., Sussman J.L. Crystal structure of Na acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target. Structure. 3:1995;1355-1366.
52. Harp J.M., Timm D.E., Bunick G.J. Macromolecular crystal annealing: overcoming increased mosaicity associated with cryocrystallography. Acta Crystallogr. D. 54:1998;622-628.
53. Hendrickson W. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science. 254:1991;51-58.
54. Hendrickson W.A., Smith J.L., Phizackerley R.P., Merritt E.A. Crystallographic structure analysis of lamprey hemoglobin from anomalous dispersion of synchrotron radiation. Proteins. 4:1988;77-88.
55. 2 from the venom of the Cottonmouth snake at 2.0 Å resolution. J. Biol. Chem. 265:1990;17649-17656.
56. Holm L., Sander C. Evaluation of proteins models by atomic solvations preference. J. Mol. Biol. 225:1992;93-105.
57. Hope H. Cryocrystallography of biological macromolecules: a generally applicable method. Acta Crystallogr. B. 44:1988;22-26.
58. Itoh N., Tanaka N., Mihashi S., Yamashina I. Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme. J. Biol. Chem. 262:1987;3132-3135.
59. Jahnke W., Mierke D.F., Beress L., Kessler H. Structure of cobra cardiotoxin CTX I as derived from nuclear magnetic resonance spectroscopy and distance geometry calculations. J. Mol. Biol. 240:(5):1994;445-458.
60. Jancarik J., Kim S.H. Sparse matrix sampling: the screening method goes crystallization of proteins. J. Appl. Crystallogr. 24:1991;409-411.
61. Jang J., Kumar T.K.S., Jayaraman G., Yang P., Yu C. Comparison of the hemolytic activity and solution structures of two snake venom cardiotoxin analogues which only differ in their N-terminal amino acid. Biochemistry. 36:1997;14635-14641.
62. Johnson E.K., Ownby C.L. Isolation of a hemorrhagic toxin from the venom of Agkistrodon contortrix laticinctus (Broad-banded copperhead) and pathogenesis of the hemorrhage induced by the toxin in mice. Int. J. Biochem. 25:(2):1993;267-278.
63. Jones T.A. Interactive computer graphics: FRODO. Methods Enzymol. 115:1985;157-171.
64. Jones T.A., Thirup S. Using known substructures in protein model building and crystallography. EMBO J. 5:(4):1986;819-822.
65. Jones, T.A., Kjeldgaard, M., 1993. 'O': the Manual, version 5.9. Upsala.
66. Kini R.M., Evans H.J. Inhibition of platelet aggregation by a fibrinogenase from Naja nigricollis venom is independent of fibrinogen degradation. Biochim. Biophys. Acta. 1095:(2):1991;117-121.
67. Kosen P.A., Finer-Moore F., McCarthy M.P., Basus V.J. Structural studies of α-bungarotoxin: corrections in the primary structure and X-ray structure and characterization of an isotoxic α-bungarotoxin. Biochemistry. 27:1988;2775-2781.
68. Koszelak S., Day J., Leja C., Cudney R., McPherson A. Protein and virus crystal growth on international microgravity laboratory-2. Biophys. J. 69:1995;13-19.
69. Krishna Murth H.M., Hendrickson W.A., Orme-Johnson W.H., Merritt E.A., Phizackerley R.P. Crystal structure of Clostridium acidic-uric Ferredoxin at 5 Å resolution based on measurements of anomalous X-ray scattering at multiple wavelengths. J. Biol. Chem. 263:1988;18430-18436.
70. Kubinyi H. Structure-based design of enzyme inhibitors and receptor ligands. Curr. Op Drug. Disc. Devel. 1:1998;4-15.
71. 2-proteinase from the venom of Trimeresurus flavoviridis. J. Biochem. 119:1996;49-57.
72. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:1993;283-291.
73. Lesk, A.M., 1997. CASP2: report on ab initio predictions. Proteins: Struct. Func. Genet. (Suppl. 1), 151-166.
74. 2 from Bothrops asper snake venom. J. Biol. Chem. 269:1994;29867-29873.
75. Lüthy R., Bowie J.U., Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 356:1992;83-85.
76. 2. Biochem. Mol. Biol. Int. 42:1997;1171-1177.
77. 2 with lysine in place of aspartate 49. J. Biol. Chem. 259:1984;13839-13843.
78. Marsh N.A. Snake venom affecting the haemostatic mechanism - a consideration of their mechanisms, practical applications and biological significance. Blood Coag. Fibrinol. 5:1994;399-410.
79. Martin, A.C.R., MacArthur, M.W., Thornton, J.M., 1997. Assessment of comparative modelling in CASP2. Proteins: Struct. Func. Genet. (Suppl. 1), 14-28.
80. Matthews B.W. Solvent content of proteins crystals. J. Mol. Biol. 33:1968;491-497.
81. McMullen B.A.A., Fujikawa K., Kisiel W. Primary structure of a protein C activator from Agkistrodon contortrix contortrix venom. Biochemistry. 28:1989;674-679.
82. McPherson A. Crystallization of proteins from polyethylene glycol. J. Biol. Chem. 251:1976;6300-6306.
83. McPherson A., Malkin A.J., Kuznetsov Y.G. The science of macromolecular crystallization. Structure. 3:1995;759-768.
84. McPherson A. Recent advances in the microgravity crystallization of biological macromolecules. Trends Biotechnol. (TIBTECH). 15:1997;197-200.
85. McRee D.E. Practical Protein Crystallography. 1993;Academic Press, San Diego, USA.
86. Mikol V., Hirsh E., Giegé R. Diagnostic of precipitant for biomacromolecule crystallization by quasi-elastic light-scattering. J. Mol. Biol. 213:1990;187-195.
87. Moss M.L., Jin S.L.C., Milla M.E., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., Warner J., Willard D., Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necroses factor-alpha. Nature. 385:1997;733-736.
88. Moura-da-Silva A.M., Laing G.D., Paine M.J., Dennison J.M., Politi V., Crampton J.M., Theakston R.D. Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite. Eur. J. Immunol. 26:(9):1996;2000-2005.
89. Nastopoulos V., Kanellopoulos P.N., Tsernoglou D. Structure of dimeric and monomeric erabutoxin a refined at 1.5 Å resolution. Acta Crystallogr. D. 54:1998;964-974.
90. Navaza J. AmoRe: an automated package for molecular replacement. Acta Crystallogr. A. 50:1994;157-163.
91. O'Connell J.F., Bougis P.E., Wuthrich K. Determination of the nuclear-magnetic-resonance solution structure of cardiotoxin CTX IIb from Naja mossambica mossambica. Eur. J. Biochem. 213:(3):1993;891-900.
92. Pannu N.S., Read R.J. Improved structure refinement through maximum likelihood. Acta Crystallogr. A. 52:1996;659-668.
93. Parry M.A.A., Jacob U., Huber R., Wisner A., Bon C., Bode W. The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases. Structure. 6:1998;1195-1206.
94. Peng S.S., Kumar T.K.S., Jayaraman G., Chang C.C., Yu C. Solution structure of toxin b, a long neurotoxin from the venom of the king cobra (Ophiophagus hannah). J. Biol. Chem. 272:(12):1997;7817-7823.
95. Perbandt M., Wilson J.C., Eschenburg S., Mancheva I., Aleksiev B., Genov N., Willingmann P., Weber W., Singh T.P., Betzel C. Crystal structure of vipoxin at 2.0 Å: an example of regulation of a toxic function generated by molecular evolution. FEBS Lett. 412:(3):1997;573-577.
96. Perutz M.F. Protein Structure, New Approaches to Disease and Therapy. 1992;W.H. Freeman and Company, New York, USA.
97. Pflugrath J.W., Saper M.A., Quiocho F.A. Hall S., Ashida J. Methods and Applications in Crystallographic Computing. 1984;Oxford University Press.
98. Ponder J.W., Richards F.M. ertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes. J. Mol. Biol. 193:(4):1987;775-791.
99. Pusey M.L. An apparatus for protein crystal growth studies. Anal. Biochem. 158:1986;50-54.
100. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260:(21):1985;11627-11634.
101. II from Naja mossambica mossambica: the refined crystal structure. J. Mol. Biol. 214:1990;281-297.
102. Rice L.M., Brünger A.T. Torsion angle dynamics: reduced variable conformational sampling enhances crystallographic structure refinement. Proteins. 19:1994;277-290.
103. Rossmann M.G., Blow D.M. The detection of sub-units within the crystallographic asymmetric unit. Acta Crystallogr. 15:1962;24-31.
104. Sayle R., Milner-White E.J. RASMOL: biomolecular graphics for all. TiBS. 20:1995;374-376.
105. 2. Nature Struct. Biol. 2:1995;458-465.
106. Schmitz K.S. An Introduction to Dynamic Light Scattering by Macromolecules. 1990;Academic Press, Boston.
107. Scopes R.K. Protein Purification, Principles and Practice. 3 :1994;Springer-Verlag New York.
108. 2. Science. 250:1990;1541-1546.
109. 2 in a complex with a transition-state analogue. Science. 250:1990;1563-1566.
110. 2 from the venom of Agkistrodon piscivorus piscivorus. J. Biol. Chem. 267:1992;22645-22657.
111. Selistre H.S., Giglio J.R. Isolation and characterization of a thrombin-like enzyme from the venom of the snake Bothrops insularis (jararaca ilhoa). Toxicon. 25:1987;1135-1144.
112. Selistre de Araújo, Queiroz L.S., Cunha O.A.B., De Souza G.E.P., Giglio J.R. Isolation and characterization of hemorrhagic, myonecrotic and edema-inducing toxins from Bothrops insularis (jararaca ilhoa) snake venom. Toxicon. 28:1990;261-273.
113. 2 myotoxin from the venom of Agkistrodon contortrix laticinctus snake venom. Arch. Biochem. Biophys. 326:1996;21-30.
114. 2 myotoxins: a highly conserved class of protein. Toxicon. 34:1996;1237-1242.
115. Serrano S.M.T., Hagiwara Y., Murayama N., Higuchi S., Mentele R., Sampaio C.A.M., Camargo C.M., Fink E. Purification and characterization of a kinin-releasing and fibrinogen-clotting serine proteinase (KN-BJ) from the venom of Bothrops jararaca and molecular cloning and sequence analysis of its cDNA. Eur. J. Biochem. 251:1998;845-853.
116. Silva Giotto M.T., Garratt R.C., Oliva G., Mascarenhas Y.P., Giglio J.R., Cintra A.C., de Azevedo W.F. Jr., Arni R.K., Ward R.J. Crystallographic and spectroscopic characterization of a molecular hinge: conformational changes in bothropstoxin I, a dimeric Lys49-phospholipase A2 homologue. Proteins. 30:(4):1998;442-454.
117. Sippl M. Recognition of errors in three-dimensional structures of proteins. Proteins: Struct. Func. Genet. 17:1993;355-362.
118. Shoham M., Yonath A., Sussman J.L., Muolt J., Traub W., Kalb A.J. Crystal structure of demetallized concanavalin A: the metal-binding region. J. Mol. Biol. 131:1979;137-155.
119. Met. Acta Crystallogr. B. 39:1983;495.
120. Teng T.Y. Mounting of crystals for macromolecular crystallography in a free-standing thin film. J. Appl. Crystallogr. 23:1990;387-391.
121. Tokunaga F., Nagasawa K., Tamura S., Miyata T., Iwanaga S., Kisiel W. The factor V-activating enzyme (RVV-V) from Russell's viper venom. Identification of isoproteins RVV-V alpha, -V beta and -V gamma and their complete amino acid sequences. J. Biol. Chem. 263:(33):1988;17471-17481.
122. 2 for the venom of Agkistrodon halys blomhoffii at 2.8 Å resolution. Biochem. Biophys. Res. Commun. 184:(1):1992;137-143.
123. Tronrud D.E., Holden H.M., Matthews B.W. Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond. Science. 235:(4788):1987;571-574.
124. 2 and their importance for enzymatic activity. J. Cell. Biochem. 39:1989;379-390.
125. 2 reveal conformational changes during interfacial activation. Nature Struct. Biol. 2:1995;402-406.
126. van den Born H.K.L., Radic Z., Marchot P., Taylor P., Tsigelny I. Theoretical analysis of the structure of the peptide fusciculin and ist docking to acetylcholinesterase. Protein Sci. 4:1995;703-713.
127. Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8:1990;52-56.
128. Vriend G., Sander C. Quality control of protein models:directional atomic contact analysis. J. Appl. Crystallogr. 26:1993;47-60.
129. 2 from the venom of Agkistrodon halys pallas at 2.0Å resolution. J. Mol. Biol. 255:1996;669-676.
130. 2. Toxicon. 36:1998;1623-1633.
131. 2: clues towards identification of residues involved in a novel mechanism of membrane damage and in mytoxicity. Protein Eng. 11:(4):1998;285-294.
132. 2 at 2.0 Å resolution. FEBS Lett. 301:(2):1992;159-164.
133. Westerlund B., Saarinen M., Person B., ramaswamy S., Eaker D., Eklund H. Crystallographic investigation of the dependence of calcium and phosphate ions for notexin. FEBS Lett. 403:1997;51-56.
134. 2 in a complex with a transition-state analogue. Science. 250:1990;1560-1563.
135. Wilson W.W. Monitoring crystallization experiments using dynamic light scattering assaying and monitoring protein crystallization in solution. Methods. 1:1990;110-117.
136. Wonnacott S.M., Dajas F. Neurotoxins: nature's untapped bounty. Trends Pharmacol. Sci. 15:1994;1-3.
137. Zhang D., Botos I., Gomis-Rüth F-X., Doll R., Blood C., Njoroge F.G., Fox J.W., Bode W., Meyer E.F. Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc. Natl. Acad. Sci. USA. 91:1994;8447-8451.
138. Zhang Y., Wisner A., Marount R.C., Choumet V., Xiong Y., Bon C. Trimeresurus stejnegeri snake venom plasminogen activator. Site directed mutagenesis and molecular modeling. J. Biol. Chem. 272:(33):1997;20531-20537.
139. Zulauf M., D'Arcy A. Light scattering of proteins as a criterion for crystallization. J. Cryst. Growth. 122:1992;102-106.